Similar to other nanoplatforms conjugated with docetaxel [75], our investigations showed that NExT significantly reduced stromal α-SMA in the PDX tumor tissue (Fig. 7b), suggesting that NExT not only can target tumor cells but also remodel the TME by the depletion of CAFs through the interaction with PDL1. This evidence concerns the gene CD274 and neoplasm.